Informatics
News on bioinformatics, software, genome analysis, variant classification, and IT in genetics, genomics, and molecular diagnostics.
Nanostics Signs on OncoHelix to Offer Prostate Cancer Risk Tool in Middle East
The deal comes on the heels of a similar arrangement Nanostics struck with Protean BioDiagnostics for the US market.
The firm has submitted its xR assay to the FDA and is prioritizing its entry into the minimal residual disease space.
Protean BioDiagnostics to Market Nanostics Prostate Cancer Risk Tool in US
The tool uses two blood-based biomarkers and up to five clinical features to generate a risk score for prostate cancer aggressiveness.
Constantiam Bio Gets $485K Grant From National Institute on Aging for Alzheimer's Tool Development
The funding will be used to advance a tool for interpreting risk variants associated with Alzheimer’s disease and related dementias.
The nonprofit behind the work aims to bring the test to market in the next 18 to 24 months and is in discussions with potential commercialization partners.